Clive Dix: Rebuilding UK biotechUK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last Share XClive Dix: Rebuilding UK biotechhttps://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/
GSK’s Neale Belson on building trust with employees and societyPharma’s reputation is currently riding high as the industry comes together to tackle COVID-19, but GSK’s UK general Share XGSK’s Neale Belson on building trust with employees and societyhttps://pharmaphorum.com/views-analysis-sales-marketing/gsks-neale-belson-on-building-trust-with-employees-and-society/
Vertex Pharma’s vision for reimbursement innovationAs regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s Share XVertex Pharma’s vision for reimbursement innovationhttps://pharmaphorum.com/views-analysis-market-access/vertex-pharmas-vision-for-reimbursement-innovation/
Ipsen’s UK & Ireland MD on adapting business to COVID-19Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has Share XIpsen’s UK & Ireland MD on adapting business to COVID-19https://pharmaphorum.com/views-and-analysis/ipsens-uk-md-on-adapting-business-to-covid-19/
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetesIn our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he Share XNovo Nordisk: Prevention, digital tools and collaboration to define the future of diabeteshttps://pharmaphorum.com/views-analysis-sales-marketing/novo-nordisk-prevention-digital-tools-and-collaboration-to-define-the-future-of-diabetes/
MSD’s David Peacock on moving UK healthcare forwardDavid Peacock has worked across the world for MSD and other companies, and has now taken the helm Share XMSD’s David Peacock on moving UK healthcare forwardhttps://pharmaphorum.com/views-analysis-sales-marketing/msds-david-peacock-on-moving-uk-healthcare-forward/
Teva’s Kim Innes on shaping the post-COVID future with the NHSLike all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her Share XTeva’s Kim Innes on shaping the post-COVID future with the NHShttps://pharmaphorum.com/views-analysis-sales-marketing/teva-kim-innes-on-shaping-the-post-covid-future-with-the-nhs/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
Daiichi Sankyo: pharma needs to become NHS ‘experts’If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership Share XDaiichi Sankyo: pharma needs to become NHS ‘experts’https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/
